国际标准期刊号: 2329-9053

分子药剂学与有机过程研究杂志

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • CAS 来源索引 (CASSI)
  • 哥白尼索引
  • 谷歌学术
  • 夏尔巴·罗密欧
  • 打开 J 门
  • 学术钥匙
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • 普布隆斯
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

Exploring the Critical Role of Pharmaceutical Microbiology in Drug Development and Safety

Stanger Gadella

The article emphasizes the significance of pharmaceutical microbiology in ensuring the safety and efficacy of
pharmaceutical products throughout the drug development and manufacturing process. It highlights the risks posed
by microbial contamination and underscores the role of pharmaceutical microbiologists in implementing quality control
measures, sterility assurance, and environmental monitoring. The abstract also touches upon emerging trends, such
as rapid microbiological methods and automation that contribute to the field's evolving importance in pharmaceutical
manufacturing. Overall, the article aims to underscore the crucial role of pharmaceutical microbiology in maintaining
product integrity, meeting regulatory requirements, and safeguarding public health.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证。